Baden LR, El Sahly HM, Essink B, Kotloff Ok, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, et al. Efficacy and Security of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021;384:403–16.
Cheng X, Liu S, Solar J, Liu L, Ma X, Li J, Fan B, Yang C, Zhao Y, Liu S, et al. A synergistic lipid nanoparticle encapsulating mRNA shingles vaccine induces potent immune responses and protects guinea pigs from viral challenges. Adv Mater. 2024;36:2310886.
Chaudhary N, Weissman D, Whitehead KA. mRNA vaccines for infectious ailments: rules, supply and medical translation. Nat Rev Drug Discov. 2021;20:817–38.
Liu C, Shi Q, Huang X, Koo S, Kong N, Tao W. mRNA-based most cancers therapeutics. Nat Rev Most cancers. 2023;23:526–43.
Lorentzen CL, Haanen JB, Met Ö, Svane IM. Medical advances and ongoing trials on mRNA vaccines for most cancers therapy. Lancet Oncol. 2022;23:e450–8.
Leppek Ok, Byeon GW, Kladwang W, Wayment-Steele HK, Kerr CH, Xu AF, Kim DS, Topkar VV, Choe C, Rothschild D, et al. Combinatorial optimization of mRNA construction, stability, and translation for RNA-based therapeutics. Nat Commun. 2022;13:1536.
Paunovska Ok, Loughrey D, Dahlman JE. Drug supply methods for RNA therapeutics. Nat Rev Genet. 2022;23:265–80.
Chen S, Huang X, Xue Y, Álvarez-Benedicto E, Shi Y, Chen W, Koo S, Siegwart DJ, Dong Y, Tao W. Nanotechnology-based mRNA vaccines. Nat Rev Strategies Primers. 2023;3:63.
Huang P, Deng H, Zhou Y, Chen X. The roles of polymers in mRNA supply. Matter. 2022;5:1670–99.
Kaczmarek JC, Patel AK, Kauffman KJ, Fenton OS, Webber MJ, Heartlein MW, DeRosa F, Anderson DG. Polymer-lipid nanoparticles for systemic supply of mRNA to the lungs. Angew Chem Int Ed. 2016;55:13808–12.
Huang P, Jiang L, Pan H, Ding L, Zhou B, Zhao M, Zou J, Li B, Qi M, Deng H, et al. An built-in polymeric mRNA vaccine with out irritation unintended effects for mobile immunity mediated most cancers remedy. Adv Mater. 2023;35:2207471.
Huang X, Kong N, Zhang X, Cao Y, Langer R, Tao W. The panorama of mRNA nanomedicine. Nat Med. 2022;28:2273–87.
Maugeri M, Nawaz M, Papadimitriou A, Angerfors A, Camponeschi A, Na M, Hölttä M, Skantze P, Johansson S, Sundqvist M, et al. Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to different cells. Nat Commun. 2019;10:4333.
O’Brien Ok, Breyne Ok, Ughetto S, Laurent LC, Breakefield XO. RNA supply by extracellular vesicles in mammalian cells and its functions. Nat Rev Mol Cell Biol. 2020;21:585–606.
Yang Z, Shi J, Xie J, Wang Y, Solar J, Liu T, Zhao Y, Zhao X, Wang X, Ma Y, et al. Massive-scale technology of practical mRNA-encapsulating exosomes by way of mobile nanoporation. Nat Biomed Eng. 2020;4:69–83.
Conde J, Ambrosone A, Sanz V, Hernandez Y, Marchesano V, Tian F, Baby H, Berry CC, Ibarra MR, Baptista PV, et al. Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing. ACS Nano. 2012;6:8316–24.
Mendes BB, Conniot J, Avital A, Yao D, Jiang X, Zhou X, Sharf-Pauker N, Xiao Y, Adir O, Liang H, et al. Nanodelivery of nucleic acids. Nat Rev Strategies Primers. 2022;2:24.
Udhayakumar VK, De Beuckelaer A, McCaffrey J, McCrudden CM, Kirschman JL, Vanover D, Van Hoecke L, Roose Ok, Deswarte Ok, De Geest BG, et al. Arginine-rich peptide-based mRNA nanocomplexes effectively instigate cytotoxic t cell immunity depending on the amphipathic group of the peptide. Adv Healthc Mater. 2017;6:1601412.
Liu X, Huang P, Yang R, Deng H. mRNA most cancers vaccines: building and boosting methods. ACS Nano. 2023;17:19550–80.
Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA supply. Nat Rev Mater. 2021;6:1078–94.
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, et al. Security and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–15.
Maraganore J. Reflections on alnylam. Nat Biotechnol. 2022;40:641–50.
Liu J, Chang J, Jiang Y, Meng X, Solar T, Mao L, Xu Q, Wang M. Quick and environment friendly CRISPR/Cas9 genome modifying in vivo enabled by bioreducible lipid and messenger RNA Nanoparticles. Adv Mater. 2019;31: e1902575.
Kim M, Jeong M, Hur S, Cho Y, Park J, Jung H, Search engine marketing Y, Woo HA, Nam KT, Lee Ok, Lee H. Engineered ionizable lipid nanoparticles for focused supply of RNA therapeutics into various kinds of cells within the liver. Sci Adv. 2021;7:eabf4398.
Cheng Q, Wei T, Farbiak L, Johnson LT, Dilliard SA, Siegwart DJ. Selective organ focusing on (SORT) nanoparticles for tissue-specific mRNA supply and CRISPR-Cas gene modifying. Nat Nanotechnol. 2020;15:313–20.
Huo H, Cheng X, Xu J, Lin J, Chen N, Lu X. A fluorinated ionizable lipid improves the mRNA supply effectivity of lipid nanoparticles. J Mater Chem B. 2023;11:4171–80.
Hassett KJ, Benenato KE, Jacquinet E, Lee A, Woods A, Yuzhakov O, Himansu S, Deterling J, Geilich BM, Ketova T, et al. Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines. Mol Ther -Nucl Acids. 2019;15:1–11.
Akinc A, Maier MA, Manoharan M, Fitzgerald Ok, Jayaraman M, Barros S, Ansell S, Du X, Hope MJ, Madden TD, et al. The Onpattro story and the medical translation of nanomedicines containing nucleic acid-based medicine. Nat Nanotechnol. 2019;14:1084–7.
Ansell S, Du X, WO2017/075531A1, 2017.
Han X, Zhang H, Butowska Ok, Swingle KL, Alameh M-G, Weissman D, Mitchell MJ. An ionizable lipid toolbox for RNA supply. Nat Commun. 2021;12:7233.
Akinc A, Zumbuehl A, Goldberg M, Leshchiner ES, Busini V, Hossain N, Bacallado SA, Nguyen DN, Fuller J, Alvarez R, et al. A combinatorial library of lipid-like supplies for supply of RNAi therapeutics. Nat Biotechnol. 2008;26:561–9.
Ramishetti S, Hazan-Halevy I, Palakuri R, Chatterjee S, Naidu Gonna S, Dammes N, Freilich I, Kolik Shmuel L, Danino D, Peer D. A combinatorial library of lipid nanoparticles for RNA supply to leukocytes. Adv Mater. 2020;32:1906128.
Chen Z, Tian Y, Yang J, Wu F, Liu S, Cao W, Xu W, Hu T, Siegwart DJ, Xiong H. Modular design of biodegradable ionizable lipids for improved mrna supply and exact most cancers metastasis delineation in vivo. J Am Chem Soc. 2023;145:24302–14.
Li B, Raji IO, Gordon AGR, Solar L, Raimondo TM, Oladimeji FA, Jiang AY, Varley A, Langer RS, Anderson DG. Accelerating ionizable lipid discovery for mRNA supply utilizing machine studying and combinatorial chemistry. Nat Mater. 2024;23:1002–8.
Liu S, Cheng Q, Wei T, Yu X, Johnson LT, Farbiak L, Siegwart DJ. Membrane-destabilizing ionizable phospholipids for organ-selective mRNA supply and CRISPR–Cas gene modifying. Nat Mater. 2021;20:701–10.
Qiu M, Tang Y, Chen J, Muriph R, Ye Z, Huang C, Evans J, Henske EP, Xu Q. Lung-selective mRNA supply of artificial lipid nanoparticles for the therapy of pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci USA. 2022;119: e2116271119.
Su Ok, Shi L, Sheng T, Yan X, Lin L, Meng C, Wu S, Chen Y, Zhang Y, Wang C, et al. Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation. Nat Commun. 2024;15:5659.
Whitehead KA, Dorkin JR, Vegas AJ, Chang PH, Veiseh O, Matthews J, Fenton OS, Zhang Y, Olejnik KT, Yesilyurt V, et al. Degradable lipid nanoparticles with predictable in vivo siRNA supply exercise. Nat Commun. 2014;5:4277.
Hu B, Li B, Li Ok, Liu Y, Li C, Zheng L, Zhang M, Yang T, Guo S, Dong X, et al. Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi therapy of hyperlipidemia. Sci Adv. 2022;8:eabm1418.
Cai W, Luo T, Chen X, Mao L, Wang M. A combinatorial library of biodegradable lipid nanoparticles preferentially ship mRNA into tumor cells to dam mutant RAS signaling. Adv Funct Mater. 2022;32:2204947.
Li B, Manan RS, Liang S-Q, Gordon A, Jiang A, Varley A, Gao G, Langer R, Xue W, Anderson D. Combinatorial design of nanoparticles for pulmonary mRNA supply and genome modifying. Nat Biotechnol. 2023;41:1410–5.
He Z, Le Z, Shi Y, Liu L, Liu Z, Chen Y. A multidimensional strategy to modulating ionizable lipids for high-performing and organ-selective mRNA supply. Angew Chem Int Ed. 2023;62: e202310401.
Dong W, Li Z, Hou T, Shen Y, Guo Z, Su Y-T, Chen Z, Pan H, Jiang W, Wang Y. Multicomponent synthesis of imidazole-based ionizable lipids for extremely environment friendly and spleen-selective messenger RNA supply. J Am Chem Soc. 2024;146:15085–95.
Chen J, Xu Y, Zhou M, Xu S, Varley AJ, Golubovic A, Lu RXZ, Wang KC, Yeganeh M, Vosoughi D, Li B. Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA supply with minimized off-target results. Proc Natl Acad Sci USA. 2023;120: e2309472120.
Miao L, Li L, Huang Y, Delcassian D, Chahal J, Han J, Shi Y, Sadtler Ok, Gao W, Lin J, et al. Supply of mRNA vaccines with heterocyclic lipids will increase anti-tumor efficacy by STING-mediated immune cell activation. Nat Biotechnol. 2019;37:1174–85.
Miao L, Lin J, Huang Y, Li L, Delcassian D, Ge Y, Shi Y, Anderson DG. Synergistic lipid compositions for albumin receptor mediated supply of mRNA to the liver. Nat Commun. 2020;11:2424.
Wei C, Li C-J. A extremely environment friendly three-component coupling of aldehyde, alkyne, and amines by way of C−H activation catalyzed by gold in water. J Am Chem Soc. 2003;125:9584–5.
Li X, Chen N, Xu, J. Microwave-Assisted CuCl-Catalyzed Three-Part Reactions of Alkynes, Aldehydes, and Amino Alcohols. Synthesis 2019, 51. 3336-44.
Dong Y, Love KT, Dorkin JR, Sirirungruang S, Zhang Y, Chen D, Bogorad RL, Yin H, Chen Y, Vegas AJ, et al. Lipopeptide nanoparticles for potent and selective siRNA supply in rodents and nonhuman primates. Proc Natl Acad Sci USA. 2014;111:3955–60.
Carrasco MJ, Alishetty S, Alameh M-G, Mentioned H, Wright L, Paige M, Soliman O, Weissman D, Cleveland TE, Grishaev A, Buschmann MD. Ionization and structural properties of mRNA lipid nanoparticles affect expression in intramuscular and intravascular administration. Commun Biol. 2021;4:956.
Campos KR, Cai D, Journet M, Kowal JJ, Larsen RD, Reider PJ. Managed semihydrogenation of aminoalkynes utilizing ethylenediamine as a poison of Lindlar’s catalyst. J Org Chem. 2001;66:3634–5.
Alabi CA, Love KT, Sahay G, Yin H, Luly KM, Langer R, Anderson DG. Multiparametric strategy for the analysis of lipid nanoparticles for siRNA supply. Proc Natl Acad Sci USA. 2013;110:12881–6.
Jayaraman M, Ansell SM, Mui BL, Tam YK, Chen J, Du X, Butler D, Eltepu L, Matsuda S, Narayanannair JK, et al. Maximizing the efficiency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew Chem Int Ed. 2012;51:8529–33.
